Month: October 2017

Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR-T therapy

Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR-T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy.

Ford Motor Company Fund and Community Services grant helps promote Teen Driver Safety Initiative at Monroe Carell Jr. Children’s Hospital at Vanderbilt

VUMC Voice 4-to-6-year-old Halloween art winners announced

Cats, bats, pumpkins and ghosts!

Resources assist staff in making EpicLeap transition seamless for patients

As Vanderbilt University Medical Center (VUMC) gears up for the Nov. 2 launch of eStar, teams throughout the medical center are hard at work to ensure the transition is seamless and positive for patients and their families.

Hidden VUMC Figures event honors crucial contributions

On Monday, the Vanderbilt University Medical Center (VUMC) Office for Diversity Affairs held the inaugural “Hidden VUMC Figures” event, a tribute to employees who have made significant long-term, often behind-the-scenes, contributions to the Medical Center.

Vanderbilt’s liver transplant program reaches new milestone

On Oct. 3 Vanderbilt University Medical Center (VUMC) performed its 2,000th liver transplant, another milestone for one of the largest liver transplant programs in the Southeast.

1 2 3 4 5 7